SCHEMBL2663566

SCHEMBL2663566

CC(C)c1cc(-c2ccc(F)cc2)c(CO)c(C(C)C)n1

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCGR P47871 16/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8877450 0.86 GCGR (0.50) GCGR
SCHEMBL6963687 0.85 GCGR (0.62) GCGR
SCHEMBL27525540 0.82 GCGR (0.46) GCGR
SCHEMBL8879135 0.82 GCGR (0.54) GCGR
SCHEMBL8877568 0.82 HMGCR (0.58) GCGR
SCHEMBL8949830 0.81 GCGR (0.45) GCGR
SCHEMBL28320987 0.80 GCGR (0.51) GCGR
SCHEMBL8878033 0.80 GCGR (0.55) GCGR
SCHEMBL8877443 0.79 GCGR (0.54) GCGR
SCHEMBL8949822 0.78 GCGR (0.88) GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218431-B1 GLUCAGON RECEPTOR ANTAGONISTS FOR THERAPY OF DIABETES AND CONDITIONS ASSOCIATED WITH DIABETES BAYER CORPORATION 2001-04-17 US disclosed
US-5691322-A Quinoline and pyridine anchors for HMG-CoA reductase inhibitors E.R. SQUIBB & SONS, INC. (US) 1997-11-25 US disclosed
US-5686433-A CHOLESTEROL BIOSYNTHESIS INHIBITION E.R. SQUIBB & SONS, INC. (US) 1997-11-11 US disclosed
US-5506219-A ANTICHOLESTEROL AND ANTILIPEMIC AGENTS E. R. SQUIBB & SONS, INC. (US) 1996-04-09 US disclosed